Cargando…

Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management

Mitochondrial cardiomyopathy (MCM) is characterized by abnormal heart-muscle structure and function, caused by mutations in the nuclear genome or mitochondrial DNA. The heterogeneity of gene mutations and various clinical presentations in patients with cardiomyopathy make its diagnosis, molecular me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jinjuan, Chen, Shaoxiang, Duan, Fuyu, Wang, Xiuxiu, Zhang, Xiaoxian, Lian, Boonxuan, Kou, Meng, Chiang, Zhixin, Li, Ziyue, Lian, Qizhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655095/ https://www.ncbi.nlm.nih.gov/pubmed/36359908 http://dx.doi.org/10.3390/cells11213511

Ejemplares similares

Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?
por: Kou, Meng, et al.
Publicado: (2022)

Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up
por: Zhang, Che, et al.
Publicado: (2022)

Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes
por: Mazzaccara, Cristina, et al.
Publicado: (2021)

Roles of the crucial mitochondrial DNA in hypertrophic cardiomyopathy prognosis and diagnosis: A review
por: Liao, Xuewen, et al.
Publicado: (2023)

Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance
por: Li, Ziyue, et al.
Publicado: (2022)

iPSC-MSCs with High Intrinsic MIRO1 and Sensitivity to TNF-α Yield Efficacious Mitochondrial Transfer to Rescue Anthracycline-Induced Cardiomyopathy
por: Zhang, Yuelin, et al.
Publicado: (2016)

Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage
por: Jiang, Dan, et al.
Publicado: (2016)

Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies
por: Cai, Chen, et al.
Publicado: (2022)

Adult mesenchymal stem cell ageing interplays with depressed mitochondrial Ndufs6
por: Zhang, Yuelin, et al.
Publicado: (2020)

The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics
por: Thakur, Abhimanyu, et al.
Publicado: (2021)

Therapeutic strategies in ischemic cardiomyopathy: Focus on mitochondrial quality surveillance
por: Chang, Xing, et al.
Publicado: (2022)

Mitochondrial Cardiomyopathies
por: El-Hattab, Ayman W., et al.
Publicado: (2016)

FGF21 Mediates Mesenchymal Stem Cell Senescence via Regulation of Mitochondrial Dynamics
por: Li, Xin, et al.
Publicado: (2019)

Epidemiology, Pathophysiology, Diagnosis, and Principles of Management of Takotsubo Cardiomyopathy: A Review
por: Matta, Anthony Georges, et al.
Publicado: (2023)

Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids
por: Jubaidi, Fatin Farhana, et al.
Publicado: (2020)

Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy
por: Li, Xuebiao, et al.
Publicado: (2018)

Hypertrophic Cardiomyopathy due to Mitochondrial Disease: Prenatal Diagnosis, Management, and Outcome
por: García-Díaz, Lutgardo, et al.
Publicado: (2013)

Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy
por: Hu, Lang, et al.
Publicado: (2019)

Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy
por: Chang, Xing, et al.
Publicado: (2023)

Prooxidant Mechanisms in Iron Overload Cardiomyopathy
por: Cheng, Ching-Feng, et al.
Publicado: (2013)

Mitochondrial Mechanisms in Septic Cardiomyopathy
por: Cimolai, María Cecilia, et al.
Publicado: (2015)

Mitochondrial Mechanisms in Diabetic Cardiomyopathy
por: Gollmer, Johannes, et al.
Publicado: (2020)

Mitochondrial Protein Homeostasis and Cardiomyopathy
por: Wachoski-Dark, Emily, et al.
Publicado: (2022)

Therapeutic Approach of Flavonoid in Ameliorating Diabetic Cardiomyopathy by Targeting Mitochondrial-Induced Oxidative Stress
por: Sapian, Syaifuzah, et al.
Publicado: (2021)

Exploring potential therapeutic agents for lipopolysaccharide-induced septic cardiomyopathy based on transcriptomics using bioinformatics
por: Feng, Shaodan, et al.
Publicado: (2023)

Application of left ventricular endomyocardial biopsy in the diagnosis of mitochondrial cardiomyopathy: a case report
por: Fang, Chuangsen, et al.
Publicado: (2023)

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
por: Jiang, Rui, et al.
Publicado: (2023)

Connexin 43-Mediated Mitochondrial Transfer of iPSC-MSCs Alleviates Asthma Inflammation
por: Yao, Yin, et al.
Publicado: (2018)

Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke
por: Zhou, Xiangyue, et al.
Publicado: (2021)

Mitochondrial Genome Variants as a Cause of Mitochondrial Cardiomyopathy
por: Campbell, Teresa, et al.
Publicado: (2022)

Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction
por: Sun, Si-Jia, et al.
Publicado: (2021)

Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy
por: Zhang, Yuelin, et al.
Publicado: (2015)

Arrhythmogenic Cardiomyopathy: Molecular Insights for Improved Therapeutic Design
por: Stevens, Tyler L., et al.
Publicado: (2020)

Highlight: Mitochondrial Mechanisms in Septic Cardiomyopathy
Publicado: (2015)

Involvement of Mitochondrial Disorders in Septic Cardiomyopathy
por: Durand, Arthur, et al.
Publicado: (2017)

Mitochondrial Function and Dysfunction in Dilated Cardiomyopathy
por: Ramaccini, Daniela, et al.
Publicado: (2021)

The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management
por: Chen, Kou-Huang, et al.
Publicado: (2022)

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease
por: Limongelli, Giuseppe, et al.
Publicado: (2018)

The therapeutic dilemma of peripartum cardiomyopathy
por: Biteker, Murat, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e9fqt63plg8udrn509q07hg1o5